TWA
TCI Wealth Advisors’s Nektar Therapeutics NKTR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,246
| Closed | -$2.82K | – | 2600 |
|
|
2022
Q4 | $2.82K | Buy |
1,246
+927
| +291% | +$2.1K | ﹤0.01% | 1887 |
|
|
2022
Q3 | $1K | Sell |
319
-191
| -37% | -$599 | ﹤0.01% | 2124 |
|
|
2022
Q2 | $2K | Buy |
+510
| New | +$2K | ﹤0.01% | 2017 |
|
|
2022
Q1 | – | Sell |
-591
| Closed | -$8K | – | 2377 |
|
|
2021
Q4 | $8K | Buy |
591
+565
| +2,173% | +$7.65K | ﹤0.01% | 1343 |
|
|
2021
Q3 | $0 | Sell |
26
-166
| -86% | – | ﹤0.01% | 2493 |
|
|
2021
Q2 | $3K | Buy |
192
+166
| +638% | +$2.59K | ﹤0.01% | 1789 |
|
|
2021
Q1 | $1K | Hold |
26
| – | – | ﹤0.01% | 2070 |
|
|
2020
Q4 | $0 | Sell |
26
-275
| -91% | – | ﹤0.01% | 1589 |
|
|
2020
Q3 | $5K | Hold |
301
| – | – | ﹤0.01% | 762 |
|
|
2020
Q2 | $7K | Buy |
301
+138
| +85% | +$3.21K | ﹤0.01% | 651 |
|
|
2020
Q1 | $3K | Sell |
163
-65
| -29% | -$1.2K | ﹤0.01% | 891 |
|
|
2019
Q4 | $5K | Hold |
228
| – | – | ﹤0.01% | 856 |
|
|
2019
Q3 | $4K | Sell |
228
-47
| -17% | -$825 | ﹤0.01% | 873 |
|
|
2019
Q2 | $10K | Buy |
275
+33
| +14% | +$1.2K | ﹤0.01% | 623 |
|
|
2019
Q1 | $8K | Buy |
242
+13
| +6% | +$430 | ﹤0.01% | 672 |
|
|
2018
Q4 | $8K | Buy |
229
+13
| +6% | +$454 | ﹤0.01% | 665 |
|
|
2018
Q3 | $13K | Buy |
216
+24
| +13% | +$1.44K | 0.01% | 578 |
|
|
2018
Q2 | $9K | Hold |
192
| – | – | ﹤0.01% | 655 |
|
|
2018
Q1 | $20K | Hold |
192
| – | – | 0.01% | 483 |
|
|
2017
Q4 | $11K | Hold |
192
| – | – | ﹤0.01% | 611 |
|
|
2017
Q3 | $5K | Hold |
192
| – | – | ﹤0.01% | 736 |
|
|
2017
Q2 | $4K | Hold |
192
| – | – | ﹤0.01% | 816 |
|
|
2017
Q1 | $5K | Hold |
192
| – | – | ﹤0.01% | 715 |
|
|
2016
Q4 | $2K | Buy |
+192
| New | +$2K | ﹤0.01% | 1030 |
|